Standard BioTools Inc. Sustainability Profile
Standard BioTools Inc., headquartered in the United States, is a pioneering company in the life sciences industry, specialising in innovative tools for biological research and diagnostics. Founded in 2019, the company has rapidly established itself as a leader in single-cell analysis and genomic technologies, providing researchers with advanced solutions that enhance precision and efficiency. With a focus on core products such as the Standard BioTools™ platform, the company offers unique capabilities in multiplexed protein analysis and genomic sequencing. These cutting-edge tools empower scientists to unlock complex biological data, driving advancements in personalised medicine and therapeutic development. Standard BioTools Inc. has garnered recognition for its commitment to innovation, positioning itself as a key player in the global market for life science tools and technologies.
DitchCarbon Score
How does Standard BioTools Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Standard BioTools Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Standard BioTools Inc.'s reported carbon emissions
Standard BioTools Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Standard BioTools Inc. does not have any publicly available commitments to reduce carbon emissions or specific initiatives aimed at addressing climate change. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, Standard BioTools Inc. remains unaligned with these emerging industry standards.
How Carbon Intensive is Standard BioTools Inc.'s Industry?
How Carbon Intensive is Standard BioTools Inc.'s Location?
Standard BioTools Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Standard BioTools Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
